Craig-Hallum Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
Contract Pharma1 天
TriLink, Avantor Team Up to Expand Nucleic Acid Access in EMEA
TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...
Le Lézard1 天
NAPCO Security Technologies, Inc. Reports Fiscal 2025 Second Quarter Results
The Board declared a quarterly dividend of $0.125 per share, payable on April 3, 2025 to shareholders of record on March 12, 2025.
Le Lézard1 天
Exact Sciences Schedules Fourth Quarter 2024 Earnings Call
Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its fourth quarter 2024 financial results after the close of the U ...
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
American Association of Individual Investors4 天
3 Undervalued Life Sciences Tools & Services Stocks for Thursday, January 30
Discover the top 3 undervalued Life Sciences Tools & Services stocks for Thursday, January 30 based on AAII’s Stock Grades.
Business Wire6 天
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...
Maravai LifeSciences expands mRNA manufacturing with new acquisition
SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...
Maravai Lifesciences jumps 6% to $5.85 after MAI IP acquisition announcement
EST Maravai Lifesciences (MRVI) jumps 6% to $5.85 after MAI IP acquisition announcementInvest with Confidence: Follow TipRanks' Top Wall ...
Maravai LifeSciences通过新收购扩展mRNA制造能力
圣地亚哥 - 市值7.96亿美元的生命科学试剂和服务供应商Maravai LifeSciences, Inc. (NASDAQ: MRVI)宣布收购Molecular Assemblies, Inc.的知识产权和资产。根据 InvestingPro 数据，该公司保持强劲的流动性，流动比率为10.74，尽管面临近期挑战，过去十二个月收入下降34%。此次收购将增强Maravai子公司TriLink ...